ArticlePreventive medicine reports2026
Rapid tobacco surveillance among young people in six states: Methods and findings from the Center for Rapid Surveillance of Tobacco Youth and Young Adult Cohort.
Article in Preventive medicine reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Commercial tobacco retail marketing in rural communities in Appalachian Kentucky, 2024.Preventive medicine reports · 2026Article
- Accelerating tobacco regulatory science in the United States: The center for rapid surveillance of tobacco.Preventive medicine reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Objective: The goal of this study is to describe the methods of the Rutgers Center for Rapid Surveillance of Tobacco Youth and Young Adult Cohort. Methods: Participants completed a multi-phase online screening process with 155 youth (ages 12-17) and 551 young adults (ages 18-25) in six U.S. states (CA, KY, NC, NJ, OH, VT) retained in the Cohort. Quarterly surveys conducted from Fall 2024-Summer 2025 assessed tobacco use behaviors and beliefs. Analyses describe retention and data quality, as well as descriptive findings on ever use, new use, susceptibility, access and sources of tobacco, and tobacco/nicotine brands used. Results: Survey retention between waves ranged from 86 to 90 %. Over nine months, new use of a specific tobacco/nicotine product occurred in 5-11 % of youth and 10-23 % of young adults who had never used that product; trial was greatest for cigars. Susceptibility was lowest among never users for smokeless tobacco and highest for electronic nicotine products (ENP). Most participants under age 21 perceived tobacco or nicotine products to be easy to access (63 %), with few reporting perceived difficulty buying in a store (29 %) or online (10 %). Geek Bar, JUUL, and RAZ were the most popular ENP brands; two write-in brands were reported consistently in VT (Loon) and NJ (Lava), with other write-in brands suggesting regional variation in brand availability. Conclusion: The Cohort complements state and national surveys, with timely findings and assessment of longitudinal patterns of behavior. Flexibility in the survey instrument allows for triangulation of product and brand uptake across the Center's activities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.